Dallas, TX (PRWEB) February 17, 2015
The clinical trial report “Crohn’s Disease Global Clinical Trials Review, H1, 2015? provides elemental information and data relating to the clinical trials on Crohn’s Disease. Nonerosive Reflux Disease (NERD) is the most common phenotypic appearance of gastroesophageal reflux disease. It occurs more usually in the ileum and colon. The cause of Crohn's disease is unidentified. Men and women are affected evenly by inflammatory bowel infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Complete report details available at http://www.rnrmarketresearch.com/crohns-disease-global-clinical-trials-review-h1-2015-market-report.html.
Symptoms of nonerosive reflux disease include diarrhea, rectal bleeding, fever, weight loss, anorexia, nausea, vomiting, malnutrition, vitamin deficiencies, bone loss, psychosocial issues. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Crohn’s Disease.
Top Companies Participating in Nonerosive Reflux Disease (NERD) Therapeutics Clinical Trials includes Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Eisai Co., Ltd., Yuhan Corporation, Ahn-Gook Pharmaceutical Co., Ltd.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
The report also includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Companies discussed in this crohn’s disease therapeutics clinical trials report include AbbVie Inc., UCB S.A., Johnson & Johnson, Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Ferring International Center S.A., C. H. Boehringer Sohn AG & Co. KG, Takeda Pharmaceutical Company Limited, Sanofi. Order a Purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=268949 . (This is a premium report priced at US$2500 for a single user License.)
The report also includes the clinical trial overview of top institutes / government that includes The National Institute of Allergy and Infectious Diseases, Jinling Hospital, Hyogo College Of Medicine, Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, University of Western Ontario, University of Pittsburgh, Vanderbilt University, University of Alberta, Academic Medical Center, University of British Columbia.
Explore more reports on Clinical Trial industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial.
More reports on Clinical Trials:
Hepatic Encephalopathy Global Clinical Trials Review, H1, 2015
This report provides elemental information and data relating to the clinical trials on Post Hepatic Encephalopathy. Companies discussed in this hepatic encephalopathy clinical trials report include Salix Pharmaceuticals Ltd., Hyperion Therapeutics, Inc., Ocera Therapeutics, Inc., CD Pharma India Private Ltd., ASKA Pharmaceutical Co., Ltd., Win Medicare Pvt. Ltd., Ono Pharmaceutical Co., Ltd.
Clinical trial overviews of top institutes or government include: Govind Ballabh Pant Hospital, New York University School of Medicine, Dayanand Medical College & Hospital, University of Catania, The Hunter Holmes McGuire VA Medical Center, Weill Cornell Medical College, Postgraduate Institute of Medical Education and Research, Aga Khan University, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Institut Recerca Hospital Universitari Vall d'Hebron. Complete report details at http://www.rnrmarketresearch.com/hepatic-encephalopathy-global-clinical-trials-review-h1-2015-market-report.html.
Fecal Incontinence Global Clinical Trials Review, H1, 2015
The report provides data on the Fecal Incontinence clinical trial scenario. Companies and Institutes discussed in this report includes Norgine B.V., RDD Pharma Ltd., Innovacell Biotechnologie AG, Salix Pharmaceuticals Ltd., S.L.A. Pharma AG, Pfizer Inc., GlaxoSmithKline plc, Cook Medical Incorporated, Anterogen Co., Ltd., Centre Hospitalier Universitaire de Nimes, University of Wisconsin Madison, U.S. Department of Veterans Affairs, The National Institute of Diabetes and Digestive and Kidney Diseases, North West London Hospitals NHS Trust, Cantonal Hospital, Aarhus University, James Cook University, Herlev Hospital, Rouen University Hospital. Complete report details at http://www.rnrmarketresearch.com/fecal-incontinence-global-clinical-trials-review-h1-2015-market-report.html.
RnRMarketResearch.com is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers.
Read the full story at http://www.prweb.com/releases/crohns-disease-global/clinical-trials-review-h1/prweb12522457.htm.
Copyright©2015 Vocus, Inc.
All rights reserved